This randomized clinical trial evaluates the efficacy of alirocumab in pediatric patients with heterozygous familial hypercholesterolemia.
Home>>Clinical Practice Guidelines>>Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
Clinical Practice Guidelines